XLO Xilio Therapeutics, Inc.

$8.77 +3.18%

Healthcare · Pharmaceutical Preparations

Xilio Therapeutics, Inc. (XLO) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $51 million. Shares last traded at $8.77, 5.6% below their 52-week high. Over the past year the stock is up 1152.9%. Net profit margin is -80.1%, below the peer median of -0.1%. Revenue grew 589.9% year over year.

Market Cap

$51M

Shares Out

5.8M

EPS (TTM)

$-3.84

P/E Ratio

—

P/S Ratio

1.16

P/B Ratio

0.70

Dividend / Share

—

Dividend Yield

—

52-Week High

$9.29

52-Week Low

$0.41

Volume

533

Avg Vol (3m)

1,091.508

Performance

+11.58%

+8.27%

+19.81%

+1246.95%

YTD

+1202.35%

+1152.86%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

62.77

SMA (50)

$8.23

SMA (200)

$3.21

Price vs SMA50

+6.58%

Price vs SMA200

+173.01%

ATR (14)

$0.39

Financials

Revenue

$44M

Net Income

$-35M

Gross Margin

—

Operating Margin

-95.9%

Net Margin

-80.1%

Return on Equity

-48.3%

Return on Assets

-21.4%

Current Ratio

3.59

Debt / Equity

1.25

Revenue Growth (YoY)

+589.9%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-0.58	2026-05-12
FY 2025	$-4.19	2026-03-23
Q3 2025	$-0.43	2025-11-13
Q2 2025	$-0.34	2025-08-14
Q1 2026	$-2.49	2026-05-12
FY 2025	$-15.24	2026-03-23

Full earnings history →

Pharmaceutical Preparations peers

XLO vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/S vs peers

1.16 / 3.54 med

-67% discount

Net margin vs peers

-80.1% / -0.1% med

below median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.